Journal profile · Multiple
Infectious Diseases and Clinical Microbiology
ISSN 2667-646X · DOC Design and Informatics Co. Ltd.
Infectious Diseases and Clinical Microbiology: CAS Zone 4 · Medicine (2025 upgraded edition); subscription journal; median 76 days to acceptance (96 articles, last 24 months); 64 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Infectious Diseases and Clinical Microbiology is published by DOC Design and Informatics Co. Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research and Antibiotic Use and Resistance, together about 29.9% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Share Print Infectious Diseases and Clinical Microbiology (Infect Dis Clin Microbiol) is an international, scientific, open-access periodical published in accordance with independent, unbiased, and double-blinded peer-review principles. The journal, launched in 2019, is the official online publication of the Turkish Society of Clinical Microbiology and Infectious Diseases (KLİMİK). The journal was published three times per year until 2021. From 2022 through 2025, it was published quarterly. Beginning in 2026, Infectious Diseases and Clinical Microbiology is published bimonthly, with six issues per year, released in January, March, May, July, September, and November. The publication language of the journal is English. Infectious Diseases and Clinical Microbiology aims to contribute to the literature by publishing manuscripts at the highest scientific level in all fields of infectious diseases and clinical microbiology. The journal publishes original articles, case reports, reviews, and letters to the editor that are prepared in accordance with ethical guidelines. The scope of the journal includes but is not limited to basic and clinical microbiology and infection-related scientific topics. The target audience of the journal includes specialists and professionals working and interested in all disciplines of infectious diseases and clinical microbiology and related medical and scientific fields. The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal is in conformity with the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice). Processing and publication are free of charge with the Journal. No fees are requested from the authors at any point throughout the evaluation and publication process. Articles are licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). All manuscripts must be submitted via the online submission system, which is available at idcmjournal.org. The journal guidelines, technical information, and the required forms are available on the Journal’s web page. All expenses of the Journal are covered by the Turkish Socie
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Murat AkovaPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named Türkiye 25, Italy 5, Switzerland 3, Sweden 3, Greece 3 (50 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- COVID-19 Clinical Research StudiesMedicine13.2%
- SARS-CoV-2 and COVID-19 ResearchMedicine9.1%
- Antibiotic Use and ResistanceImmunology and Microbiology7.6%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology6.6%
- Antifungal resistance and susceptibilityMedicine4.3%
- Sepsis Diagnosis and TreatmentMedicine4.3%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology4.3%
- Vaccine Coverage and HesitancySocial Sciences4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Infectious Diseases | Q4 | 312/361 | 13th |
| Microbiology (medical) | Q4 | 134/147 | 9th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.6LetPub ·
- SJR 2026-06
- 0.2LetPub ·
- SNIP 2026-06
- 0.34LetPub ·
- h-index
- 10OpenAlex ·
- i10-index
- 13OpenAlex ·
- 2-year mean citedness
- 1.07OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 96.24%LetPub ·
Volume
- Articles per year
- 51LetPub ·
Articles by year OpenAlex count · 387 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 63 | 63 | 243 |
| 2025 | 64 | 61 | 171 |
| 2024 | 52 | 47 | 112 |
| 2023 | 52 | 47 | 63 |
| 2022 | 54 | 49 | 69 |
| 2021 | 35 | 30 | 48 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
76 daysMedian, submission to acceptance · P25–P75 50 days – 115 days
- Acceptance to online
- median 96 days (96 articles)
- Submission to online
- median 181 days
- Sample
- 96 articles with submission and acceptance dates (123 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted12
- brief reportOriginal Articles: This is the most important type of article since it provides new information based on original research. The main text of original articles s…Length not stated
- case reportOriginal Articles: This is the most important type of article since it provides new information based on original research. The main text of original articles s…Length not stated
- case reportsCase Reports: There is limited space for case reports in the Journal and reports on rare cases or conditions that constitute challenges in diagnosis and treatme…Length not stated
- commentaryOriginal Articles: This is the most important type of article since it provides new information based on original research. The main text of original articles s…Length not stated
- editorialOriginal Articles: This is the most important type of article since it provides new information based on original research. The main text of original articles s…Length not stated
- original articleOriginal Articles: This is the most important type of article since it provides new information based on original research. The main text of original articles s…Length not stated
- original articlesOriginal Articles: This is the most important type of article since it provides new information based on original research.Length not stated
- original researchOriginal Articles: This is the most important type of article since it provides new information based on original research. The main text of original articles s…Length not stated
- research articleOriginal Articles: This is the most important type of article since it provides new information based on original research. The main text of original articles s…Length not stated
- reviewOriginal Articles: This is the most important type of article since it provides new information based on original research. The main text of original articles s…Length not stated
- review articleOriginal Articles: This is the most important type of article since it provides new information based on original research. The main text of original articles s…Length not stated
- review articlesReview Articles: Reviews prepared by authors who have extensive knowledge of a particular field and whose scientific background has been translated into a high …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Publication ethics, License & copyright, Peer review, Plagiarism, Preprints
- AI use Use of Large Language Models and Generative AI Tools
“AI tools cannot meet the requirements for authorship as they cannot take responsibility for the submitted work. As non-legal entities, they cannot assert the presence or absence of conflicts of interest nor manage copyright and license agreements. Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of …
Source ↗Publisher website ·- Authorship Authorship
Each individual listed as an author should fulfill the authorship criteria recommended by the International Committee of Medical Journal Editors (ICMJE – www.icmje.org). The ICMJE recommends that authorship be based on the following 4 criteria: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND Drafting the w…
Source ↗Publisher website ·- Publication ethics
COPE guidelines for misconduct. Model summary
In the event of alleged or suspected research misconduct, e.g., plagiarism, citation manipulation, and data falsification/fabrication, the Editorial Board will follow and act in accordance with COPE guidelines.
Source ↗Publisher website ·- License & copyright Copyright
Infectious Diseases and Clinical Microbiology requires each submission to be accompanied by a Copyright License Agreement form. By signing the Copyright License Agreement, the authors agree that the article, if accepted for publication by the Infectious Diseases and Clinical Microbiology, will be licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC-BY-NC 4.0). …
Source ↗Publisher website ·- Peer review Peer-review Process
Double-blind peer review. Model summary
Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Submitted to Infectious Diseases and Clinical Microbiology will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in their fields in order to ensure an unbiase…
Source ↗Publisher website ·- Plagiarism
Similarity screening with Grammarly. Model summary
All submissions are screened by similarity detection software (Grammarly).
Source ↗Publisher website ·- Preprints
Archiving via Internet Archive. Model summary
The content published by IDCM is electronically preserved using the Internet Archive (https://archive.org/details/idcm-journal) to ensure its availability to scientists and researchers.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- DOC Design and Informatics Co. Ltd.
- ISSN
- 2667-646X
- Society / sponsor
- Turkish Society Of Clinical Microbiology and Infectious Diseases
- Latest issue on the website
- Volume 8, Issue 4 (July 2026)
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Infectious Diseases and Clinical Microbiology
What CAS zone is Infectious Diseases and Clinical Microbiology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Infectious Diseases and Clinical Microbiology is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases / Microbiology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Infectious Diseases and Clinical Microbiology?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 76 days (interquartile range 50–115 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Infectious Diseases and Clinical Microbiology based?
Of the 50 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are Türkiye (25), Italy (5) and Switzerland (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Infectious Diseases and Clinical Microbiology?
According to LetPub and DOAJ records, Infectious Diseases and Clinical Microbiology is indexed in ESCI and Scopus.
Is Infectious Diseases and Clinical Microbiology open access, and what is the APC?
Infectious Diseases and Clinical Microbiology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .